Plasmid-based uveitis therapy proceeding to phase I trial


Biotech company Eyevensys has received approval from the French national regulatory agency ANSM to advance its nonviral gene therapy platform to clinical development.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/plasmid-based-uveitis-therapy-proceeding-to-phase-i-trial/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s